- Home
- PAYC vs SRPT Comparison
PAYC vs SRPT Comparison
Compare PAYC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYC
- SRPT
- Stock Information
- Founded
- PAYC 1998
- SRPT 1980
- Country
- PAYC United States
- SRPT United States
- Employees
- PAYC N/A
- SRPT N/A
- Industry
- PAYC Computer Software: Prepackaged Software
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- PAYC Technology
- SRPT Health Care
- Exchange
- PAYC Nasdaq
- SRPT Nasdaq
- Market Cap
- PAYC 13.3B
- SRPT 12.2B
- IPO Year
- PAYC 2014
- SRPT 1997
- Fundamental
- Price
- PAYC $209.08
- SRPT $123.37
- Analyst Decision
- PAYC Hold
- SRPT Buy
- Analyst Count
- PAYC 11
- SRPT 21
- Target Price
- PAYC $202.56
- SRPT $179.38
- AVG Volume (30 Days)
- PAYC 597.8K
- SRPT 852.6K
- Earning Date
- PAYC 02-05-2025
- SRPT 02-26-2025
- Dividend Yield
- PAYC 0.72%
- SRPT N/A
- EPS Growth
- PAYC 42.02
- SRPT N/A
- EPS
- PAYC 8.29
- SRPT 1.22
- Revenue
- PAYC $1,823,922,000.00
- SRPT $1,640,348,000.00
- Revenue This Year
- PAYC $12.65
- SRPT $50.56
- Revenue Next Year
- PAYC $10.59
- SRPT $70.57
- P/E Ratio
- PAYC $25.21
- SRPT $101.14
- Revenue Growth
- PAYC 11.92
- SRPT 48.45
- 52 Week Low
- PAYC $139.50
- SRPT $91.34
- 52 Week High
- PAYC $242.74
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- PAYC 37.52
- SRPT 50.85
- Support Level
- PAYC $203.90
- SRPT $117.40
- Resistance Level
- PAYC $236.57
- SRPT $128.73
- Average True Range (ATR)
- PAYC 6.63
- SRPT 3.65
- MACD
- PAYC -4.34
- SRPT -0.51
- Stochastic Oscillator
- PAYC 13.34
- SRPT 42.92
About PAYC Paycom Software Inc.
Paycom is a fast-growing provider of payroll and human capital management software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 19,500 clients as of 2023, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.